Home › Citigroup Inc. Initiates Coverage on Teva Pharmaceutical Industries Ltd
 

Keywords :   


Citigroup Inc. Initiates Coverage on Teva Pharmaceutical Industries Ltd

2013-10-27 07:18:34| Biotech - Topix.net

The firm set a "buy" rating and a $47.00 price target on the stock. Citigroup Inc.'s price objective suggests a potential upside of 12.71% from the stock's previous close.

Tags: ltd industries coverage pharmaceutical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06XREAL bring Play Store apps to 3D space on XREAL AR glasses
26.06Qwilt reveals live streaming survey results
26.06Rockline Industries Wins WOW Innovation Award
26.06IMS Technologies Expands Calcinate Production Site
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
More »